The United States has one of the highest rates of oral and systemic allergies in the world, with about one in three Americans experiencing a reaction to an oral medication, according to the World Health Organization.
That means that the U.S. is the only country in the industrialized world with such a high rate of allergies.
Kynia has a long history of growing and selling its herbal medicine in the United States.
The company has expanded its operations to Canada, Mexico and the United Kingdom, and it is now working with pharmaceutical companies to market the products there, according.
The company is also working to open an in-country distribution center in Mexico City that will have a similar focus to what it has done in the U .
The plant is used in folk remedies, such as a tea called tek, which is made from the roots of the leaves of a plant called kyanyam, and which can be brewed into a thick, potent herbal tea.
It can be used to treat symptoms of food poisoning, according kyanna herbal medicine’s website.
Its not just the herb that is used.
The roots are often used in traditional Chinese medicine and acupuncture, and the leaves are often mixed with a fermented soybean oil, which can boost the absorption of nutrients.
The tea is also sold as a vitamin supplement, and some kyanas have also developed a kyanchenic, or holistic, approach to their herbal medicines.
The brand is currently on sale at pharmacies in Australia, Canada, Colombia, Greece, Italy, Japan, Mexico, Poland, Russia and Turkey.
Kyans traditional herbal medicine is made using traditional Chinese and Indian herbal techniques, and is also available as a natural supplement in herbal tea and capsules.
Its ingredients are carefully sourced and the company uses no pesticides, herbicides, fungicides, fertilizers or genetically modified organisms.
The product is sold under the brand name of Kynia herbal medicine.
The herbal product is also often referred to as kyan herbal medicine as it is known for its ability to heal conditions ranging from eczema to rheumatoid arthritis.
“It’s a unique product that has proven to be a very effective treatment for rheumatic pain,” said Rupal Shukla, a physician in clinical and pharmaceutical medicine at the University of California, San Francisco.
The brand is also being sold by the popular online marketplace Amazon, where users can purchase the herb for about $3.00 a kilogram.
In China, the herbal medicine sells for around $150 a kilo, which translates to about $30,000 a year.
The health of the kyanskas people has been a constant focus for kyana herbal medicine and it has become a favorite for Chinese consumers, who tend to pay more for their products than Western consumers, said Shuklla.
It is also gaining popularity in Europe, with a growing number of Westerners coming to the brand to find out what kyanes herbal medicine can do for them.
The kyano brand was also chosen as one of China’s top five herbal brands in a list of the top 10 herbal products, according the China Health Association.
The association also awarded kyanos herbal medicine the prestigious title of “world’s best-selling herbal medicine.”
Kyna has expanded the business to sell herbal products in China and India, as well as other countries.
Its Chinese and India business was worth $1.4 billion in 2015.
Kymna’s sales have grown every year since its launch in the 1990s.
The first year of the brand’s success, it had sales of $1 million and was on track to break the $5 million mark for the first time in its history, according Toi Wong, co-founder and president of the company.
Its growth continues to this day, with Kyna generating more than $400 million in revenue last year, including sales of nearly $80 million in China.
But in the last three years, sales have plateaued.
The Chinese market has become increasingly crowded with companies offering similar products and the Chinese government is trying to restrict access to kyane herbal medicine by banning its use in certain industries and businesses.
The government said that kyannas herbal medicine was dangerous to consumers and that it was not recommended for use in the face of cancer.
The government has not done much to curb the availability of kyanya herbal medicine on the mainland.
However, Chinese authorities are trying to get kyankas herbal product out of China by limiting its sales and introducing restrictions on importation, according a recent press release from the Chinese Ministry of Industry and Information Technology.
While kyas sales have dropped in China, it is still the most popular herbal medicine brand in the country, according data compiled by the company from sales in 2013 to 2015.
The sales in 2014 were $2